Insomnia and parasomnias following a stroke are treated using temporary hypnotic drug therapies, such as zolpidem or benzodiazepines.
The annual incidence of stroke is 2 to 18 per 1000 individuals.
Sleep loss and sleep complaints are associated with heart attacks and potentially stroke, according to several epidemiological studies including Eaker et al. (1992), Qureshi et al. (1997), Schwartz et al. (1998), Newman et al. (2000), Ayas et al. (2003), Bradley et al. (2005), and Caples et al. (2005).
60 to 70 percent of individuals who have suffered a stroke exhibit sleep-disordered breathing with an apnea-hypopnea index of 10 or greater.
The article 'Obstructive sleep apnea as a risk factor for stroke and death' by Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, and Mohsenin V was published in the New England Journal of Medicine in 2005, volume 353, issue 19, pages 2034–2041.
Treatments for hypersomnia are not always as effective following a stroke.
The Institute of Medicine (US) Committee on Sleep Medicine and Research associates chronic sleep loss and sleep disorders with an increased risk of hypertension, diabetes, obesity, depression, heart attack, and stroke.
Stroke often alters an individual's sleep architecture, resulting in a decrease in total sleep time, REM sleep, and slow-wave sleep (SWS).
Following a stroke, an individual's sleep architecture is often altered, resulting in a decrease in total sleep time, REM sleep, and slow-wave sleep (SWS), as reported by Broughton and Baron (1978).
An observational cohort study of 1,022 individuals found that obstructive sleep apnea syndrome (defined as an apnea-hypopnea index of 5 or higher) significantly increased the risk of stroke or death from any cause, independent of other risk factors such as hypertension.
In a 10-year observational study, patients with untreated severe obstructive sleep apnea (apnea-hypopnea index greater than 30) had a higher incidence of fatal and nonfatal cardiovascular events—including myocardial infarction, stroke, and coronary artery bypass surgery—compared to patients with similar severity who received CPAP treatment.
Insomnia is a common complication of stroke that may result from medication, inactivity, stress, depression, and brain damage.
Studies by Ayas et al. (2003) and Gami et al. (2005) confirmed that obstructive sleep apnea syndrome is associated with an increased risk of stroke or death from any cause.
A 10-year follow-up study from NHANES I by Qureshi et al. (1997) examined the relationship between habitual sleep patterns and the risk for stroke and coronary heart disease.
Bassetti CL authored a chapter on sleep and stroke in the 4th edition of Principles and Practice of Sleep Medicine, published by Elsevier/Saunders in 2005.
Sleep loss and sleep complaints are associated with heart attacks (myocardial infarction) and potentially stroke, as evidenced by several large epidemiological studies and one case-control study.
Sleep-wake disturbances are found in at least 20 percent of stroke patients.
The annual incidence of stroke is 2 to 18 per 1000 individuals, and sleep-wake disturbances are found in at least 20 percent of stroke patients, according to Bassetti (2005).
The cumulative effects of sleep loss and sleep disorders are associated with an increased risk of hypertension, diabetes, obesity, depression, heart attack, and stroke.
Dyken ME, Somers VK, Yamada T, Ren ZY, and Zimmerman MB investigated the relationship between stroke and obstructive sleep apnea.
Stroke results in a sudden loss of consciousness, sensation, and voluntary movement caused by the disruption of blood flow and oxygen supply to the brain.
Chronic sleep loss and sleep disorders are associated with an increased risk of hypertension, diabetes, obesity, depression, heart attack, and stroke.
Treatments for hypersomnia are not always as effective following a stroke, according to Bassetti (2005).
Epilepsy is the third most common neurological disorder in the United States, following stroke and Alzheimer’s disease, with an incidence rate between 1.5 and 3.1 percent.
There are no specific therapies that relieve sleep-related symptoms caused by a stroke; treatments depend on the specific symptoms and are similar to the treatments of sleep disorders that arise independent of a stroke.
Studies by Dyken et al. (1996) and Bassetti et al. (1996) found that 60 to 70 percent of individuals who have suffered a stroke exhibit sleep-disordered breathing with an apnea-hypopnea index of 10 or greater.
Dyken et al. (1996) investigated the relationship between stroke and obstructive sleep apnea.
Several large epidemiological studies (Eaker et al., 1992; Qureshi et al., 1997; Schwartz et al., 1998; Newman et al., 2000; Ayas et al., 2003; et al., 2005; Bradley et al., 2005; Caples et al., 2005) and one case-control study (Liu et al., 2002) associate sleep loss and sleep complaints with heart attacks (myocardial infarction) and potentially stroke.
Obstructive sleep apnea is a risk factor for stroke and death, according to a 2005 study by Yaggi et al. published in the New England Journal of Medicine.
In the Sleep Heart Health Study, participants in the highest apnea-hypopnea index quartile had an adjusted odds ratio of 1.58 (95% CI, 1.02–2.46) for stroke.
Over 70 percent of individuals who have suffered a mild stroke and are under 75 years of age suffer from fatigue, according to Carlsson et al. (2003).
Bassetti et al. (1996) conducted a prospective study of 59 patients which examined the prevalence of sleep apnea in individuals who had experienced a transient ischemic attack or stroke.
Good DC et al. published research in Stroke in 1996 linking sleep-disordered breathing to poor functional outcomes after stroke.
Yaggi et al. (2005) identified obstructive sleep apnea as a risk factor for stroke and death.
Carlsson GE, Moller A, and Blomstrand C conducted a 1-year follow-up study on the consequences of mild stroke in persons under 75 years of age, published in Cerebrovascular Disease in 2003.
The Sleep Heart Health Study, a cross-sectional study of nearly 6,500 participants, found that individuals in the highest apnea-hypopnea index quartile (index greater than 11) were 42 percent more likely to self-report cardiovascular disease, including coronary heart disease, heart failure, or stroke, compared to those in the lowest quartile (adjusted OR = 1.42, 95% CI, 1.13–1.78).
Risk factors for stroke include heart disease, hypertension, alcohol abuse, transient ischemic attacks, and possibly sleep-disordered breathing, according to Diaz and Sempere (2004).
Sleep-disordered breathing may contribute to the development of hypertension, coronary artery disease, congestive heart failure, arrhythmias, stroke, glucose intolerance, and diabetes.
Multiple studies, including those by Bassetti and Aldrich (1999), Parra et al. (2000), Yaggi et al. (2005), and Bradley et al. (2005), support the finding that obstructive sleep apnea (OSA) is associated with a higher probability of stroke.
Stroke is defined as a sudden loss of consciousness, sensation, and voluntary movement caused by the disruption of blood flow and oxygen supply to the brain.
Parra O, Arboix A, Bechich S, Garcia-Eroles L, Montserrat JM, Lopez JA, Ballester E, Guerra JM, and Sopena JJ published a study in the American Journal of Respiratory and Critical Care Medicine in 2000 regarding the time course of sleep-related breathing disorders in patients who experienced a first-ever stroke or transient ischemic attack.
Systemic effects of sleep-disordered breathing, such as altered vascular tone, inflammatory mediator levels, and hormonal changes, may contribute to the development of hypertension, coronary artery disease, congestive heart failure, arrhythmias, stroke, glucose intolerance, and diabetes.